Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Fredun Pharmaceuticals has informed BSE that its trading window for dealing in company securities will remain closed for designated persons and their immediate relatives starting Wednesday, October 1, 2025. The window will reopen 48 hours after the conclusion of the Board Meeting that approves the unaudited financial results for the quarter and half year ended September 30, 2025. The closure is being implemented as per SEBI's Prohibition of Insider Trading Regulations, 2015, and the company's internal Code of Conduct. The intimation has been signed by Managing Director Fredun Nariman Medhora.
This is a routine regulatory compliance announcement and not an operational event. No direct impact on shareholders or stock price is expected, though the upcoming Board Meeting for Q2/H1 FY26 results is the next catalyst to watch.